PTO Form 1478 (Rev 9/2006)
`
`OMB No. 0651-0009 (Exp 12/31/2011)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 77740164
`Filing Date: 05/19/2009
`
`The table below presents the data as entered.
`
`Input Field
`
`Entered
`
`SERIAL NUMBER
`
`MARK INFORMATION
`
`*MARK
`
`STANDARD CHARACTERS
`
`USPTO-GENERATED IMAGE
`
`LITERAL ELEMENT
`
`MARK STATEMENT
`
`REGISTER
`
`APPLICANT INFORMATION
`
`*OWNER OF MARK
`
`INTERNAL ADDRESS
`
`*STREET
`
`*CITY
`
`*COUNTRY
`
`*ZIP/POSTAL CODE
`(Required for U.S. applicants only)
`
`LEGAL ENTITY INFORMATION
`
`TYPE
`
`77740164
`
`TEVTUX
`
`YES
`
`YES
`
`TEVTUX
`
`The mark consists of standard characters, without claim to any
`particular font, style, size, or color.
`
`Principal
`
`TEVA Pharmaceutical Industries Ltd.
`
`Har Hotzvim, P.O. Box 1142
`
`Science Based Industries Campus,
`
`Jersulaem
`
`Israel
`
`91010
`
`limited company (ltd.)
`
`STATE/COUNTRY WHERE LEGALLY ORGANIZED
`
`Israel
`
`GOODS AND/OR SERVICES AND BASIS INFORMATION
`
`INTERNATIONAL CLASS
`
`*IDENTIFICATION
`
`FILING BASIS
`
`ATTORNEY INFORMATION
`
`NAME
`
`ATTORNEY DOCKET NUMBER
`
`FIRM NAME
`
`INTERNAL ADDRESS
`
`STREET
`
`CITY
`
`005(cid:160)
`
`Pharmaceutical preparations containing rituximab
`
`SECTION 1(b)
`
`Lisa A. Pieroni
`
`TEVTUX
`
`Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`
`5th Floor
`
`425 Fifth Avenue
`
`New York
`
`

`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`FAX
`
`EMAIL ADDRESS
`
`New York
`
`United States
`
`10016-2223
`
`212-697-3750
`
`212-949-1690
`
`lap@kirschsteinlaw.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`OTHER APPOINTED ATTORNEY
`
`David B. Kirschstein, Alan Israel and Martin W. Schiffmiller
`
`DOMESTIC REPRESENTATIVE INFORMATION
`
`NAME
`
`FIRM NAME
`
`INTERNAL ADDRESS
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP CODE
`
`PHONE
`
`FAX
`
`Lisa A. Pieroni
`
`Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`
`5th Floor
`
`425 Fifth Avenue
`
`New York
`
`New York
`
`United States
`
`10016-2223
`
`212-697-3750
`
`212-949-1690
`
`EMAIL ADDRESS
`
`lap@kirschsteinlaw.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`CORRESPONDENCE INFORMATION
`
`NAME
`
`FIRM NAME
`
`INTERNAL ADDRESS
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`FAX
`
`EMAIL ADDRESS
`
`Lisa A. Pieroni
`
`Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`
`5th Floor
`
`425 Fifth Avenue
`
`New York
`
`New York
`
`United States
`
`10016-2223
`
`212-697-3750
`
`212-949-1690
`
`lap@kirschsteinlaw.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`FEE INFORMATION
`
`NUMBER OF CLASSES
`
`FEE PER CLASS
`
`*TOTAL FEE DUE
`
`Yes
`
`1
`
`325
`
`325
`
`

`
`*TOTAL FEE PAID
`
`SIGNATURE INFORMATION
`
`SIGNATURE
`
`SIGNATORY'S NAME
`
`SIGNATORY'S POSITION
`
`DATE SIGNED
`
`325
`
`/Lisa A. Pieroni/
`
`Lisa A. Pieroni
`
`Attorney
`
`05/19/2009
`
`

`
`PTO Form 1478 (Rev 9/2006)
`
`OMB No. 0651-0009 (Exp 12/31/2011)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 77740164
`Filing Date: 05/19/2009
`
`To the Commissioner for Trademarks:
`
`MARK:(cid:160)TEVTUX(cid:160)(Standard Characters, see mark)
`The literal element of the mark consists of TEVTUX.
`The mark consists of standard characters, without claim to any particular font, style, size, or color.
`
`The applicant, TEVA Pharmaceutical Industries Ltd., a limited company (ltd.) legally organized under the laws of Israel, having an address of
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Har Hotzvim, P.O. Box 1142,
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Science Based Industries Campus,
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Jersulaem 91010
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Israel
`requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register
`established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) International Class 005: (cid:160)Pharmaceutical preparations containing rituximab
`Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on
`or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).
`
`The applicant's current Attorney Information:
`Lisa A. Pieroni and David B. Kirschstein, Alan Israel and Martin W. Schiffmiller of Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)5th Floor
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)425 Fifth Avenue
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10016-2223
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`The attorney docket/reference number is TEVTUX.
`
`The applicant hereby appoints Lisa A. Pieroni of Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)5th Floor
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)425 Fifth Avenue
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York New York 10016-2223
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
`The applicant's current Correspondence Information:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Lisa A. Pieroni
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Kirschstein, Israel, Schiffmiller & Pieroni, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)5th Floor
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)425 Fifth Avenue
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10016-2223
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)212-697-3750(phone)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)212-949-1690(fax)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)lap@kirschsteinlaw.com (authorized)
`
`A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).
`
`Declaration
`
`The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under
`18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting
`registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be
`
`

`
`the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she
`believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or
`association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely,
`when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all
`statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
`
`Signature: /Lisa A. Pieroni/(cid:160)(cid:160)(cid:160)Date Signed: 05/19/2009
`Signatory's Name: Lisa A. Pieroni
`Signatory's Position: Attorney
`
`RAM Sale Number: 8188
`RAM Accounting Date: 05/19/2009
`
`Serial Number: 77740164
`Internet Transmission Date: Tue May 19 13:07:11 EDT 2009
`TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-200905191307116840
`12-77740164-400d69beaa779cef9711bdf34b5c
`25b31a-DA-8188-20090519130014701120
`
`

`
`TEVTUX